Beales P F
Ann Trop Med Parasitol. 1997 Oct;91(7):713-8. doi: 10.1080/00034989760446.
Mortality from malarial anaemia and malarial infection in those who are already anaemic yet have some degree of compensation is now beginning to receive the attention it deserves. It is of particular concern in Africa and especially in young children and pregnant women. The asymptomatic parasitaemia remaining after poor response to full antimalarial treatment may lead to life-threatening anaemia; as drug-resistant strains of the malarial parasite proliferate this is becoming increasingly important. It is now possible to estimate haemoglobin levels, simply, cheaply, easily and safely, using a haemoglobin colour scale which is being developed by the World Health Organization. The potential and practical value of this scale in malaria-control programmes was demonstrated in a small, preliminary trial in 1995. Estimation of anaemia should become an additional parameter in the traditional malariometric survey. Haemoglobin concentrations should also be taken into consideration in the management of malaria patients at the primary-care level, particularly in deciding whether a patient should be referred to an appropriate treatment centre. The accurate prediction of clinical outcome of malaria and anaemia, and indication of the appropriate action (determined by a case-based reasoning device) should be possible in the near future.
对于那些已经贫血但仍有一定程度代偿能力的人而言,疟疾性贫血和疟疾感染导致的死亡率如今开始受到应有的关注。这在非洲尤其令人担忧,特别是在幼儿和孕妇中。对抗疟全疗程治疗反应不佳后残留的无症状寄生虫血症可能导致危及生命的贫血;随着疟原虫耐药菌株的扩散,这一问题变得越来越重要。现在,利用世界卫生组织正在研制的血红蛋白比色卡,可以简单、廉价、便捷且安全地估算血红蛋白水平。1995年的一项小型初步试验证明了该比色卡在疟疾控制项目中的潜在价值和实际应用价值。贫血评估应成为传统疟疾病情调查中的一个附加参数。在基层医疗层面管理疟疾患者时,也应考虑血红蛋白浓度,尤其是在决定患者是否应转诊至合适的治疗中心时。在不久的将来,准确预测疟疾和贫血的临床结局以及指明适当的行动(由基于案例的推理设备确定)应该是可行的。